NCT00148382View on ClinicalTrials.gov

Study of the Blood Levels and Effects of ATL-962 on Fat Excretion in Obese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

July 31, 2005

Conditions
Obesity
Interventions
DRUG

ATL-962

Trial Locations (1)

33181

SFBCI, Miami

Sponsors

Lead Sponsor

Alizyme
All Listed Sponsors
lead

Alizyme

INDUSTRY

NCT00148382 - Study of the Blood Levels and Effects of ATL-962 on Fat Excretion in Obese Subjects | Biotech Hunter | Biotech Hunter